DURMUŞ, Ö. Et Al. 2022. Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis. DERMATOLOGIC THERAPY , vol.35, no.5 .

DURMUŞ, Ö., AKDOĞAN, N., KARADAĞ, Ö., & GÖKÖZ, Ö., (2022). Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis. DERMATOLOGIC THERAPY , vol.35, no.5.

DURMUŞ, ÖYKÜ Et Al. "Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis," DERMATOLOGIC THERAPY , vol.35, no.5, 2022

DURMUŞ, ÖYKÜ Et Al. "Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis." DERMATOLOGIC THERAPY , vol.35, no.5, 2022

DURMUŞ, Ö. Et Al. (2022) . "Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis." DERMATOLOGIC THERAPY , vol.35, no.5.

@article{article, author={ÖYKÜ DURMUŞ Et Al. }, title={Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis}, journal={DERMATOLOGIC THERAPY}, year=2022}